Diagnostic and Research Aspects of Small Intestinal Disaccharidases in Coeliac Disease

被引:1
作者
Suligoj, Tanja [1 ]
Ciclitira, Paul J. [1 ]
Bozic, Borut [2 ]
机构
[1] St Thomas Hosp, Rayne Inst, Kings Coll London, Gastroenterol, London SE1 7EH, England
[2] Univ Ljubljana, Fac Pharm, Askerceva 7, SI-1000 Ljubljana, Slovenia
关键词
GLUTEN-SENSITIVE ENTEROPATHY; CHENOPODIUM-QUINOA WILLD; IN-VITRO; ORGAN-CULTURE; VILLOUS ATROPHY; EPITHELIAL ORGANOIDS; ENZYME-ACTIVITIES; GLIADIN PEPTIDE; STEM-CELLS; T-CELL;
D O I
10.1155/2017/1042606
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Disaccharidases (DS) are brush border enzymes embedded in the microvillous membrane of small intestinal enterocytes. In untreated coeliac disease (CD), a general decrease of DS activities is seen. This manuscript reviews different aspects of DS activities in CD: their utility in the diagnosis and their application to in vitro toxicity testing. The latter has never been established in CD research. However, with the recent advances in small intestinal organoid techniques, DS might be employed as a biomarker for in vitro studies. This includes establishment of self-renewing epithelial cells raised from tissue, which express differentiation markers, including the brush border enzymes. Determining duodenal DS activities may provide additional information during the diagnostic workup of CD: (i) quantify the severity of the observed histological lesions, (ii) provide predictive values for the grade of mucosal villous atrophy, and (iii) aid diagnosing CD where minor histological changes are seen. DS can also provide additional information to assess the response to a gluten-free diet as marked increase of their activities occurs four weeks after commencing it. Various endogenous and exogenous factors affecting DS might also be relevant when considering investigating the role of DS in other conditions including noncoeliac gluten sensitivity and DS deficiencies.
引用
收藏
页数:8
相关论文
共 82 条
[1]   Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies [J].
Adriaanse, M. P. M. ;
Tack, G. J. ;
Passos, V. Lima ;
Damoiseaux, J. G. M. C. ;
Schreurs, M. W. J. ;
van Wijck, K. ;
Riedl, R. G. ;
Masclee, A. A. M. ;
Buurman, W. A. ;
Mulder, C. J. J. ;
Vreugdenhil, A. C. E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) :482-490
[2]  
ANAND BS, 1981, Q J MED, V50, P83
[3]   JEJUNAL MUCOSAL ENZYMES IN UNTREATED AND TREATED CELIAC-DISEASE [J].
ANDERSEN, KJ ;
SCHJONSBY, H ;
SKAGEN, DW .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 (02) :251-256
[4]  
[Anonymous], 2012, J Pediatr Gastroenterol Nutr, V55 Suppl 2, pS1
[5]  
BERG NO, 1973, SCAND J GASTROENTERO, V8, P703
[6]  
BERTELOOT A, 1979, IN VITRO CELL DEV B, V15, P294
[7]  
Biagi F, 1999, ALIMENT PHARM THERAP, V13, P945
[8]   No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates [J].
Biesiekierski, Jessica R. ;
Peters, Simone L. ;
Newnham, Evan D. ;
Rosella, Ourania ;
Muir, Jane G. ;
Gibson, Peter R. .
GASTROENTEROLOGY, 2013, 145 (02) :320-+
[9]  
Bluth M. H., 2007, HENRYS CLIN DIAGNOSI, P279
[10]  
Brown I, 2006, ARCH PATHOL LAB MED, V130, P1020